These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 16888199)
21. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463 [TBL] [Abstract][Full Text] [Related]
22. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor. Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136 [TBL] [Abstract][Full Text] [Related]
23. Expression of pituitary adenylate cyclase activating polypeptide and its type I receptor mRNAs in human placenta. Koh PO; Won CK; Noh HS; Cho GJ; Choi WS J Vet Sci; 2005 Mar; 6(1):1-5. PubMed ID: 15785117 [TBL] [Abstract][Full Text] [Related]
24. Pituitary adenylate cyclase activating polypeptide and PAC1 receptor signaling increase Homer 1a expression in central and peripheral neurons. Girard BM; Keller ET; Schutz KC; May V; Braas KM Regul Pept; 2004 Dec; 123(1-3):107-16. PubMed ID: 15518900 [TBL] [Abstract][Full Text] [Related]
25. Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. von Wichert G; Jehle PM; Hoeflich A; Koschnick S; Dralle H; Wolf E; Wiedenmann B; Boehm BO; Adler G; Seufferlein T Cancer Res; 2000 Aug; 60(16):4573-81. PubMed ID: 10969809 [TBL] [Abstract][Full Text] [Related]
26. PACAP and type I PACAP receptors in human prostate cancer tissue. Moretti C; Mammi C; Frajese GV; Mariani S; Gnessi L; Arizzi M; Wannenes F; Frajese G Ann N Y Acad Sci; 2006 Jul; 1070():440-9. PubMed ID: 16888207 [TBL] [Abstract][Full Text] [Related]
27. Possible involvement of PACAP and PACAP type 1 receptor in GnRH-induced FSH β-subunit gene expression. Kanasaki H; Purwana IN; Mijiddorj T; Oride A; Miyazaki K Regul Pept; 2011 Apr; 167(2-3):227-32. PubMed ID: 21329727 [TBL] [Abstract][Full Text] [Related]
28. Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system. Ahrén B Ann N Y Acad Sci; 2008 Nov; 1144():28-35. PubMed ID: 19076360 [TBL] [Abstract][Full Text] [Related]
29. Neuroleptic Drugs and PACAP Differentially Affect the mRNA Expression of Genes Encoding PAC1/VPAC Type Receptors. Jóźwiak-Bębenista M; Kowalczyk E Neurochem Res; 2017 Apr; 42(4):943-952. PubMed ID: 27900577 [TBL] [Abstract][Full Text] [Related]
30. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland. Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629 [TBL] [Abstract][Full Text] [Related]
31. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. Vaccari S; Latini S; Barberi M; Teti A; Stefanini M; Canipari R J Endocrinol; 2006 Oct; 191(1):287-99. PubMed ID: 17065411 [TBL] [Abstract][Full Text] [Related]
32. Pituitary adenylate cyclase activating polypeptide-mediated intracrine signaling in the testicular germ cells. Li M; Funahashi H; Mbikay M; Shioda S; Arimura A Endocrine; 2004 Feb; 23(1):59-75. PubMed ID: 15034198 [TBL] [Abstract][Full Text] [Related]
33. Pituitary adenylate cyclase-activating polypeptide receptors of types I and II and glucagon-like peptide-I receptors are expressed in the rat medullary carcinoma of the thyroid cell line 6/23. Vertongen P; Ciccarelli E; Woussen-Colle MC; De Neef P; Robberecht P; Cauvin A Endocrinology; 1994 Oct; 135(4):1537-42. PubMed ID: 7925114 [TBL] [Abstract][Full Text] [Related]
34. A constitutively active pituitary adenylate cyclase activating polypeptide (PACAP) type I receptor shows enhanced photoaffinity labeling of its highly glycosylated form. Cao Y; Gimpl G Biochim Biophys Acta; 2001 Jul; 1548(1):139-51. PubMed ID: 11451447 [TBL] [Abstract][Full Text] [Related]
35. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1. Njaine B; Martins RA; Santiago MF; Linden R; Silveira MS Eur J Neurosci; 2010 Aug; 32(3):311-21. PubMed ID: 20646049 [TBL] [Abstract][Full Text] [Related]
36. Spinal astrocytic activation contributes to both induction and maintenance of pituitary adenylate cyclase-activating polypeptide type 1 receptor-induced long-lasting mechanical allodynia in mice. Yokai M; Kurihara T; Miyata A Mol Pain; 2016; 12():. PubMed ID: 27175011 [TBL] [Abstract][Full Text] [Related]
37. Differential coupling of the PAC1 SV1 splice variant on human colonic tumors to the activation of intracellular cAMP but not intracellular Ca2+ does not activate tumor proliferation. Germano PM; Le SV; Oh DS; Fan R; Lieu S; Siu A; Pisegna JR J Mol Neurosci; 2004; 22(1-2):83-92. PubMed ID: 14742913 [TBL] [Abstract][Full Text] [Related]
38. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue. García-Fernández MO; Collado B; Bodega G; Cortés J; Ruíz-Villaespesa A; Carmena MJ; Prieto JC Gynecol Endocrinol; 2005 Jun; 20(6):327-33. PubMed ID: 16019382 [TBL] [Abstract][Full Text] [Related]
39. Doxycycline exerted neuroprotective activity by enhancing the activation of neuropeptide GPCR PAC1. Yu R; Zheng L; Cui Y; Zhang H; Ye H Neuropharmacology; 2016 Apr; 103():1-15. PubMed ID: 26700245 [TBL] [Abstract][Full Text] [Related]